Pàgina inicial > Resultats de la cerca: Marignier, Romain
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
15 p, 2.0 MB Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability / Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz, Anne (Centre de Recherche en Neurosciences de Lyon) ; Richard, Chloé (Centre de Recherche en Neurosciences de Lyon) ; Blondel, Sandrine (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cavagna, Sylvie (Centre de Recherche en Neurosciences de Lyon) ; Strazielle, Nathalie (BIP Facility (França)) ; Ghersi-Egea, Jean-François (BIP Facility (França)) ; Giraudon, Pascale (Centre de Recherche en Neurosciences de Lyon) ; Marignier, Romain (Centre de Recherche en Neurosciences de Lyon) ; Universitat Autònoma de Barcelona
Neuromyelitis optica spectrum disorders (NMOSD) is a primary astrocytopathy driven by antibodies directed against the aquaporin-4 water channel located at the end-feet of the astrocyte. Although blood-brain barrier (BBB) breakdown is considered one of the key steps for the development and lesion formation, little is known about the molecular mechanisms involved. [...]
2020 - 10.1371/journal.pone.0238301
PloS one, Vol. 15 (september 2020)  
Registre complet - Creative Commons
2.
11 p, 1.3 MB Multicentre comparison of a diagnostic assay : aquaporin-4 antibodies in neuromyelitis optica / Waters, Patrick (University of Oxford) ; Reindl, Markus (Medical University of Innsbruck) ; Saiz, Albert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Schanda, Kathrin (Medical University of Innsbruck) ; Tuller, Friederike (Medical University of Innsbruck) ; Kral, Vlastimil (Zdravotni ustav se sidlem v Usti nad Labem, Centrum imunologie a mikrobiologie) ; Nytrova, Petra (Charles University. Faculty of Medicine in Hradec Králové) ; Sobek, Ondrej (Topelex Ltd) ; Nielsen, Helle Hvilsted (Odense University Hospital (Dinamarca)) ; Barington, Torben (Odense University Hospital (Dinamarca)) ; Lillevang, Søren T. (Odense University Hospital (Dinamarca)) ; Illes, Zsolt (University of Pécs) ; Rentzsch, Kristin (Euroimmun AG) ; Berthele, Achim (Klinikum rechts der Isar der TU München, Klinik für Neurologie) ; Berki, Tímea (University of Pécs) ; Granieri, Letizia (Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre) ; Bertolotto, Antonio (Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre) ; Giometto, Bruno (Azienda ULSS 9 Treviso) ; Zuliani, Luigi (Azienda ULSS 9 Treviso) ; Hamann, Dörte (Sanquin Diagnostic Services, Department of Immunopathology and Blood Coagulation, Amsterdam) ; van Pelt, E. Daniëlle (MS Centre ErasMS, Erasmus MC) ; Hintzen, Rogier (MS Centre ErasMS, Erasmus MC) ; Höftberger, Romana (Medical University of Vienna. Institute of Neurology) ; Costa, Carme (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Siva, Aksel (Istanbul University, Cerrahpasa Medical School) ; Altintas, Ayse (Istanbul University, Cerrahpasa Medical School) ; Deniz, Günnur (Istanbul University, Institute of Experimental Medicine) ; Woodhall, Mark (University of Oxford) ; Palace, Jacqueline (University of Oxford) ; Paul, Friedemann (Charité - Universitätsmedizin Berlin) ; Hartung, Hans-Peter (Heinrich-Heine-University Düsseldorf) ; Aktas, Orhan (Heinrich-Heine-University Düsseldorf) ; Jarius, Sven (University of Heidelberg) ; Wildemann, Brigitte (University of Heidelberg) ; Vedeler, Christian (Haukeland University Hospital (Bergen, Noruega)) ; Ruiz, Anne (Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team) ; Leite, M. Isabel (University of Oxford) ; Trillenberg, Peter (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Probst, Monika (Institute for Quality Assurance) ; Saschenbrecker, Sandra (Euroimmun AG) ; Vincent, Angela (University of Oxford) ; Marignier, Romain (Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team) ; Universitat Autònoma de Barcelona
Antibodies to cell surface central nervous system proteins help to diagnose conditions which often respond to immunotherapies. The assessment of antibody assays needs to reflect their clinical utility. [...]
2016 - 10.1136/jnnp-2015-312601
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 87 (april 2016) , p. 1005-1015  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem